JZP-258
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for JZP-258, covering 2020-11-12 to 2021-11-24. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension [Phase 3]